Related Experiment Videos
Induced chronic intravascular coagulation in dogs.
Summary
Continuous infusion of dog brain thromboplastin into dogs primarily lowered platelets and factor XI. Other clotting factors showed dose-dependent decreases with some recovery, while fibrinogen and factor V sometimes increased.
Area of Science:
- Hematology
- Coagulation Science
Background:
- Thromboplastin plays a crucial role in the coagulation cascade.
- Understanding the effects of continuous thromboplastin administration is vital for hemostasis research.
Purpose of the Study:
- To investigate the impact of sustained dog brain thromboplastin emulsion infusion on canine coagulation factors.
- To determine the dose-dependency and recovery patterns of clotting factors under continuous thromboplastin exposure.
Main Methods:
- Continuous intravenous infusion of dog brain thromboplastin emulsion in dogs for 1-4 weeks.
- Monitoring of platelet counts and various clotting factor levels (including fibrinogen, factor V, and factor XI).
Main Results:
- Platelets and factor XI were consistently depressed throughout the infusion period.
- Other clotting factors exhibited dose-dependent reductions, with a notable tendency towards recovery despite ongoing thromboplastin administration.
- Fibrinogen and factor V showed unique behavior, occasionally increasing without an initial decline, particularly with weaker thromboplastin emulsions.
Conclusions:
- Continuous thromboplastin infusion significantly impacts platelet counts and specific clotting factors.
- The coagulation system demonstrates complex adaptive responses, including partial recovery and unique factor behavior, to sustained thromboplastin exposure.
- Findings highlight the differential sensitivity of clotting factors to thromboplastin and suggest potential regulatory mechanisms in hemostasis.